NEW YORK, Jan. 15, 2015 /PRNewswire/ -- Analyst Report Issued by Small Cap IR. ScripsAmerica, Inc. ( OTCBB: SCRC) – According to a recent report by Research and Markets, the global pharmaceuticals wholesale and distribution market is expected to grow at a compound annual growth rate of 6.82% over the period 2014-2019. According to this report, one of the major drivers of demand for various drugs and medicines, as well as basic healthcare services, are growing populations, increased consumer purchasing power, and rising health awareness. According to Drug Channels Institute, in the United States alone, wholesale drugs are a $300 billion industry.
ScripsAmerica provides supply chain management for the distribution of pharmaceutical products. The company focuses on the development, branding, and distribution of disintegrating (dissolving) drug formulations for over-the-counter ("OTC") drugs, vitamins, and supplements; the support and financing of pharmaceutical supply chain management services to independent pharmacies; and the management of specialty pharmacy business.
A brief analyst report on SCRC that includes company overview, analyst summary, recommendation, positive and negative aspects of the company can be viewed by using the following link at no cost:
Copy and paste to browser may be required.
About Small Cap IR
An issuer of reports written by chartered financial analysts (CFA's) who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release please use contact information provided below.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Contact: [email protected]
SOURCE Small Cap IR